Novel therapeutic strategies in the treatment of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a heterogeneous subtype of breast cancer that is defined by negative estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status. Treating patients with TNBC remains clinically challenging, as patients are not...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Adv Med Oncol
Hlavní autoři: Oualla, Karima, El-Zawahry, Heba M., Arun, Banu, Reuben, James M., Woodward, Wendy A., Gamal El-Din, Heba, Lim, Bora, Mellas, Nawfel, Ueno, Naoto T., Fouad, Tamer M.
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2017
Témata:
Reviews
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5502951/
https://ncbi.nlm.nih.gov/pubmed/28717401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834017711380
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky